All Type of News
Novartis to launch Stalevo, anti-parkinson drug.
Novartis Korea launched Stalevo a combined anti-parkinson drug with levo-dopa/carbidopa/entacapone,, on May 2.
The company said that 50% of the patients who treated with Levo-dopa, which was developed in 1960s for ...
97 drug makers including Han All under administrative measures.
According to the Yakup Press survey, about 226 drug companies were penalized with administrative measures during the first quarter of this year on account of the quality problems and no compliance of due labelling, in...
Il Dong achieved 197.3 BW sales and 7.3% operating income.
Il Dong reported on April 29 for the FY2004 business performance (April 1, 2004 to Mar. 31, 2005) at 197.3 billion won of sales, about 15% up from the previous year of 210 billion won and 31,417 million of the operati...
Pfizer and Jeil to extend distribution agreement with Lyrica
The distribution agreement made between Pfizer Korea and Jeil Pharm. Co. will expire on May 31, 2005 and therefore mutually agreed to extend it on April 28 for an ongoing distribution of Lipitor and Neurontin in addit...
Vita500 shared half of total Kwangdong's sales.
Vita500 of Kwangdong remarkably grew up last year, which was a half of the total Kwangdong's revenue of 187,288 million won, and 4 times more than the previous year of 85,438 million won (341,086 thousand bottles).
...
Dong-A grew up with all major products except Bacchus.
Dong-A, the top drug company in Korea, reported that Bacchus, a popular tonic drink in Korea, sold 152 billion won (508,390 thousand bottles) in 2004, showing a slight down from the previous years of 196.9 billion won...
Japan to put more weigh on generic drug markets.The Japanese drug markets having traditionally prevailed with branded drugs seemed to shift more to generic drugs after improving its business concept and undertaking an M&A of ...
|
KPA to supplement insufficient Zuellig deals
The Korea Pharmaceutical Association (KPA) took the 2nd top executive meeting of the city and provincial associations on April 26 and decided to supplement the distribution agreements of Zuellig Pharma Korea.
In th...
SPA calls for correction of Vita500 event.
The Pharmacy Committee of the Seoul Pharmaceutical Association summoned the responsible personnel of Kwangdong Pharmaceutical Co. on April 27 to convey the complaints raised from the pharmacy communities over the Vita...
Drug industry to drive speedy growth strategies
Most of the drug makers of the fiscal year ending at Mar. 31 announced speedy business growth strategies in the coming fiscal year ensuing the previous year, largely focusing on the so far neglected OTC drug markets. ...
